Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial

Autor: Braithwaite, Irene E., Cai, Fang, Tom, Jennifer A., Galanter, Joshua M., Owen, Ryan P., Zhu, Rui, Williams, Mathew, McGregor, Anna G., Eliahu, Avi, Durk, Matthew R., Dengler, Hart S., Zak, Mark, Kenny, Jane R., Wilson, Maria E., Beasley, Richard, Chen, Hubert
Zdroj: In The Journal of Allergy and Clinical Immunology September 2021 148(3):783-789
Databáze: ScienceDirect
Externí odkaz: